A potential new way to make a good anti-leukemia drug even better
Monday, October 20, 2008 - 09:22
in Health & Medicine
A recently identified cancer-causing protein makes the anti-leukemia drug imatinib, less effective. By blocking the protein, an international team of researchers was able to slow the spread of leukemia cells in culture. The study, which will appear online on October 20 in the Journal of Experimental Medicine, suggests that the most effective treatment for leukemia may rely on a combination of targeted drugs, rather than a single miracle drug.
Read the whole article on Physorg
More from Physorg
Related
- A potential new way to make a good anti-leukemia drug even betterMon, 20 Oct 2008, 10:23:52 EDT
- Combining math and medicine to treat leukemiaThu, 19 Jun 2008, 21:15:17 EDT
- Finding key to cancer drug Gleevec's limitationsWed, 5 Aug 2009, 9:57:46 EDT
- Enhancing the effects of the drug used to treat chronic myeloid leukemiaMon, 13 Apr 2009, 17:57:05 EDT
- UCSD researchers identify potential new drug target for chronic leukemiaMon, 24 Nov 2008, 18:01:16 EST